Loading clinical trials...
Loading clinical trials...
RAP-IC Study: Impact of Cardiac Rehabilitation Adapted for Patients With Heart Failure
The aim of the study is to evaluate whether a tailored cardiac rehabilitation program, initiated during hospitalization and continued after discharge, can improve functional capacity, mobility, and quality of life in patients over 65 years old with heart failure.
If you meet the inclusion criteria and wish to participate, an initial assessment of your clinical and functional status will be conducted during your hospital stay. A computer system will then randomly assign you to one of the following groups: Cardiac Rehabilitation Group (treatment group): You will participate in a mild exercise program during hospitalization (Phase I), including mobility and respiratory exercises adapted to your clinical condition. After discharge, you will enter a structured in-person cardiac rehabilitation program (Phase II) lasting 3 months, consisting of two 1-hour exercise sessions per week (aerobic, strength, inspiratory, and proprioceptive exercises) plus one weekly educational session. Usual Care Group (control group): You will receive standard recommendations for physical activity and general care. At the end of the study, a final consultation will be conducted to assess differences between the two groups in functional capacity and quality of life.
Age
65 - No limit years
Sex
ALL
Healthy Volunteers
No
Hospital Universitario Puerta de Hierro
Majadahonda, Madrid, Spain
Start Date
January 30, 2026
Primary Completion Date
January 1, 2027
Completion Date
January 1, 2028
Last Updated
January 20, 2026
114
ESTIMATED participants
Cardiac rehabilitation program
OTHER
Lead Sponsor
Puerta de Hierro University Hospital
NCT07191730
NCT07484009
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions